Precision Medicine Strategies for Treating Cardiovascular Disease
Tuesday April 07, 2020
8:00 am
-
10:00 am
Eastern Time (ET)
Room 15 B
CVP
DDD
Chair :
Hemal Patel
University of California, San Diego
Eric Gross
Stanford University
During this symposium, we will discuss strategies based on omics to develop precision medicine for cardiovascular disease. The topic is timely since the integration of omics into medical treatment and care is occurring at a rapid pace. Topics include describing how different omics data (genomic, metabolomic and exosomic) can lay the groundwork for developing precision medicine.
Speakers
Che-Hong Chen
- Stanford University
Leveraging Genetics to Develop Drugs, Such as Alda-1, to Treat Cardiovascular Disease
Isabella Kilanowski-Doroh
- Tulane University School of Medicine
Impact of GPER, Sex, and Age on Arterial Stiffness and Fibrotic Gene Expression
David Roth
- University of California, San Diego
The Exosome as an -Omics Tool to Developing Precision Medicine for Cardiac Injury and Repair
Sarah Jimenez MacInnes
- MyoKardia
Precision Cardiovascular Medicine for Genetically Driven Cardiomyopathies
Kyle LaPenna
- LSU Health Sciences Center
Development and Characterization of a Novel Small Animal Model of Heart Failure with Preserved
Ejection Fraction
Brinda Rana
- University of California, San Diego
The NASA Twins Study: What Space Flight can Reveal about Cardiovascular Metabolomics